TipRanks
Go Ultimate55% OFF

Dermisonics (DMSI) Financial Statements

Dermisonics Financial Overview

Dermisonics's market cap is currently $831. The company's EPS TTM is ―; its P/E ratio is 0.00; Dermisonics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Sep 06Sep 05Sep 04Sep 03
Income Statement
Total Revenue――――
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -4.49M$ -6.20M$ -3.93M$ -81.38K
EBITDA$ -4.49M$ -6.20M$ -3.92M$ -66.17K
Net Income$ -5.08M$ -6.96M$ -3.99M$ -82.50K
Balance Sheet
Cash & Short-Term Investments――――
Total Assets$ 20.08M$ 19.91M$ 19.45M$ 35.92K
Total Debt$ 3.12M$ 3.74M$ 2.47M$ 0.00
Net Debt$ 3.00M$ 3.38M$ 2.47M$ -3.40K
Total Liabilities$ 4.47M$ 4.15M$ 3.33M$ 8.64K
Stockholders' Equity――――
Cash Flow
Free Cash Flow$ -1.31M$ -1.23M$ -562.90K$ -74.66K
Operating Cash Flow――――
Investing Cash Flow――――
Financing Cash Flow――――

Currency in USD